Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del

用于靶向删除的复合磁性纳米粒子的受控功能化

基本信息

  • 批准号:
    7473306
  • 负责人:
  • 金额:
    $ 17.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application aims to develop composite magnetic nanoparticles with controlled surface functionalization and stability in physiological conditions for applications in targeted delivery of platin-like anticancer molecules to tumor cells, and, specifically to study the effectiveness of the platin nanoparticles in elimination of the glioma cells. The work is based on our preliminary research on the synthesis and surface functionalization of monodisperse magnetic iron-based nanoparticles, including Fe3O4, core/shell Fe/Fe3O4, and dumbbell-like Au-Fe3O4 nanoparticles, and may lead to a solution for highly efficient platin-based cancer therapy in the near future. The multifunctional nanostructures proposed here are illustrative of the exciting possibilities that can emerge from the union of nanoscience and medicine. The selective delivery of therapeutic drugs to malignant tissues constitutes one of the greatest challenges in cancer research. We propose that carefully designed bifunctional nanoparticles may provide an exciting practical vehicle to achieve selective and efficacious platin drug delivery. The composite nanoparticles, as shown in Figure 1, have both magnetic iron oxide and optically active noble metal of Au (or Ag) nanoparticle units. The different surface chemistry offered by this composite structure will facilitate the simultaneous attachment of special peptides and cisplatin-like anticancer drugs for the target specific cell recognition and cell entry. The detailed surface functionalization of the composite nanoparticles is also shown in Figure 1, in which the Fe3O4 particles are coated with a monoclonal antibody (Ab) or peptides via polyethylene glycol (PEG) and dopamine and the Au nanoparticles are linked to a TAT-like peptide (Nuclear Localization signal, NLS) through a platin complex and PEG unit. The monoclonal antibody will be used to target an antigen on the surface of tumor cells, while the NLS is to induce nanoparticle penetration through nuclear membrane. When the functionalized nanoparticles are within the tumor cell nucleus, an alternating magnetic field will be applied to remotely heat the magnetic nanoparticles, and the resultant heat will break the Pt-O bond in the structure and induce the formation of an active Pt coordination site that can readily attach to DNA strands, leading to the interruption of the DNA excision repair system and consequent cell death. The composite nanoparticles can also serve as highly sensitive multifunctional labels for the detection of trajectories of the particles within the cells by either magnetic resonance image (MRI) on iron oxide nanoparticles or electron/optical microscopic image on Au (or Ag), facilitating quantification of transporter-conjugate uptake in tumor cells. The ultimate goal of this application is to provide nanoparticle based therapeutics for successful cancer therapy.
描述(由申请人提供):本申请旨在开发具有控制表面功能和稳定性的复合磁性纳米颗粒,用于在生理条件下用于针对靶向铂类似铂样抗癌分子向肿瘤细胞的靶向递送,特别是研究铂纳米颗粒在消除Glioma细胞中的有效性。这项工作基于我们对单分散磁铁基纳米颗粒的合成和表面功能化的初步研究,包括Fe3O4,Core/Shell/Shell/Shell Fe/Fe3O4和类似Dumbbell类的Au-Fe3O4纳米颗粒,并可能导致近乎未来的高效基于Platin的癌症治疗的解决方案。这里提出的多功能纳米结构说明了纳米科学和医学结合所产生的令人兴奋的可能性。将治疗药物的选择性递送到恶性组织中是癌症研究中最大的挑战之一。我们建议精心设计的双功能纳米颗粒可能会提供令人兴奋的实用工具,以实现选择性和有效的Platin药物输送。如图1所示,复合纳米颗粒具有磁氧化铁和光活性贵金属的Au(或Ag)纳米颗粒单元。这种复合结构提供的不同表面化学反应将促进特殊肽和顺铂样抗癌药物的同时附着,以实现特异性细胞识别和细胞进入。 The detailed surface functionalization of the composite nanoparticles is also shown in Figure 1, in which the Fe3O4 particles are coated with a monoclonal antibody (Ab) or peptides via polyethylene glycol (PEG) and dopamine and the Au nanoparticles are linked to a TAT-like peptide (Nuclear Localization signal, NLS) through a platin complex and PEG unit.单克隆抗体将用于靶向肿瘤细胞表面的抗原,而NLS则是通过核膜诱导纳米颗粒穿透。当功能化的纳米颗粒位于肿瘤细胞核内时,将应用一个交替的磁场来远程加热磁性纳米颗粒,并且所得的热量会破坏结构中的PT-O键,并诱导活跃的PT坐标位点的形成,可以轻松地连接到DNA链中,从而导致DNA启动系统中断,并导致DNA Exciention Secciention Sectimentimissimentimentions extimentions Exentimentions Pections。复合纳米颗粒还可以用作高度敏感的多功能标签,用于通过氧化铁纳米颗粒上的磁共振图像(MRI)检测细胞内颗粒的轨迹,或在AU(或AG)上进行电子/光学显微镜图像,从而促进Tumor intryporter-conjugaugate uptake in Tumor in tumor in tumor in tumor intake in tumor intake in tumor cill in tumor in tumor cill in tumor cill。该应用的最终目标是为成功的癌症治疗提供基于纳米颗粒的治疗剂。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Conjugating Methotrexate to magnetite (Fe(3)O(4)) nanoparticles via trichloro-s-triazine.
  • DOI:
    10.1039/b902373a
  • 发表时间:
    2009-01-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Young KL;Xu C;Xie J;Sun S
  • 通讯作者:
    Sun S
Size and Concentration Effect of Gold Nanoparticles on X-ray Attenuation As Measured on Computed Tomography.
  • DOI:
    10.1021/cm8008418
  • 发表时间:
    2008-07-08
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Xu, Chenjie;Tung, Glenn A.;Sun, Shouheng
  • 通讯作者:
    Sun, Shouheng
Recent Progress in Syntheses and Applications of Dumbbell-like Nanoparticles.
  • DOI:
    10.1002/adma.200900320
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    29.4
  • 作者:
    Wang, Chao;Xu, Chenjie;Zeng, Hao;Sun, Shouheng
  • 通讯作者:
    Sun, Shouheng
Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin.
FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition.
  • DOI:
    10.1021/ja905938a
  • 发表时间:
    2009-10-28
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Xu, Chenjie;Yuan, Zhenglong;Kohler, Nathan;Kim, Jaemin;Chung, Maureen A.;Sun, Shouheng
  • 通讯作者:
    Sun, Shouheng
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shouheng Sun其他文献

Shouheng Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shouheng Sun', 18)}}的其他基金

Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del
用于靶向删除的复合磁性纳米粒子的受控功能化
  • 批准号:
    7280228
  • 财政年份:
    2007
  • 资助金额:
    $ 17.17万
  • 项目类别:

相似国自然基金

抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
  • 批准号:
    82300829
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
靶向CLDN18.2抗体的抗原结合特性对CAR-T抗肿瘤活性的调控机制
  • 批准号:
    82303716
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
靶向诱导抗原特异的TH1-like TFH细胞分化促进新冠特异的中和抗体长效应答及机制研究
  • 批准号:
    92269115
  • 批准年份:
    2022
  • 资助金额:
    80.00 万元
  • 项目类别:
    重大研究计划
靶向乙肝表面抗原的单链抗体及其衍生物抑制乙肝病毒和亚病毒颗粒分泌及其机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
基于抗体的新型抗原靶向肽及其药物偶联物的构建、抗肿瘤活性及作用机制研究
  • 批准号:
    82173674
  • 批准年份:
    2021
  • 资助金额:
    55.00 万元
  • 项目类别:
    面上项目

相似海外基金

Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 17.17万
  • 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
  • 批准号:
    10574346
  • 财政年份:
    2023
  • 资助金额:
    $ 17.17万
  • 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
  • 批准号:
    10658665
  • 财政年份:
    2023
  • 资助金额:
    $ 17.17万
  • 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
  • 批准号:
    10648346
  • 财政年份:
    2023
  • 资助金额:
    $ 17.17万
  • 项目类别:
High-throughput identification and transcriptional analysis of autoreactive T cells in individuals with membranous nephropathy.
膜性肾病患者自身反应性 T 细胞的高通量鉴定和转录分析。
  • 批准号:
    10725558
  • 财政年份:
    2023
  • 资助金额:
    $ 17.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了